Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Abstract LB310: Methylation synthetic lethality: SMARCA1 methylation and inhibition of pyrimidine synthesis

Hideyuki Takeshima, Yui Ohashi, Ryoma Mashiko, Toshikazu Ushijima

Cancer Res (2025) 85 (8_Supplement_2): LB310.

https://doi.org/10.1158/1538-7445.AM2025-LB310

Published: 25 April 2025

View article titled, Abstract LB310: Methylation synthetic lethality: SMARCA1 methylation and inhibition of pyrimidine synthesis

Journal Articles

Abstract 695: Relative importance between DNA methylation and mutation in nonmalignant tissue for cancer risk

Harumi Yamada, Satoshi Yamashita, Yu-Yu Liu, Toshikazu Ushijima

Cancer Res (2025) 85 (8_Supplement_1): 695.

https://doi.org/10.1158/1538-7445.AM2025-695

Published: 21 April 2025

View article titled, Abstract 695: Relative importance between DNA methylation and mutation in nonmalignant tissue for cancer risk

Journal Articles

Abstract 7016: Plastic epigenome in youth: Insights from open chromatin in stem cells

Yu-Yu Liu, Chihiro Takeuchi, Satoshi Yamashita, Toshikazu Ushijima

Cancer Res (2024) 84 (6_Supplement): 7016.

https://doi.org/10.1158/1538-7445.AM2024-7016

Published: 22 March 2024

View article titled, Abstract 7016: Plastic epigenome in youth: Insights from open chromatin in stem cells

Journal Articles

Abstract 4410: The CpG island methylator phenotype is closely associated with prognosis in patients with oral squamous cell carcinomas

Masanobu Abe, Satoshi Yamashita, Toshikazu Ushijima, Kazuto Hoshi

Cancer Res (2024) 84 (6_Supplement): 4410.

https://doi.org/10.1158/1538-7445.AM2024-4410

Published: 22 March 2024

View article titled, Abstract 4410: The CpG island methylator phenotype is closely associated with prognosis in patients with oral squamous cell carcinomas

Journal Articles

Abstract 6024: Precancerous nature of intestinal metaplasia with accelerated DNA methylation along with altered epigenomic landscape

Chihiro Takeuchi, Satoshi Yamashita, Yu-Yu Liu, Hideyuki Takeshima, Toshikazu Ushijima

Cancer Res (2023) 83 (7_Supplement): 6024.

https://doi.org/10.1158/1538-7445.AM2023-6024

Published: 04 April 2023

View article titled, Abstract 6024: Precancerous nature of intestinal metaplasia with accelerated DNA methylation along with altered epigenomic landscape

Journal Articles

Abstract 6015: Methylation synthetic lethality: CHFR methylation and KRAS inhibition in gastric cancers

Hideyuki Takeshima, Takahiro Ebata, Yumi Furuichi, Satoshi Yamashita, Toshikazu Ushijima

Cancer Res (2023) 83 (7_Supplement): 6015.

https://doi.org/10.1158/1538-7445.AM2023-6015

Published: 04 April 2023

View article titled, Abstract 6015: Methylation synthetic lethality: CHFR methylation and KRAS inhibition in gastric cancers

Journal Articles

Abstract 6014: Cancer risk diagnosis by epimutation burden: a multicenter prospective study

Harumi Yamada, Masahiro Maeda, Seiichiro Abe, Taichi Shimazu, Takayuki Ando, Kazunari Murakami, Shinji Tanaka, Takao Maekita, Osamu Inatomi, Ken Sugimoto, Tetsuro Kawagoe, Nobutake Yamamichi, Toshikazu Ushijima

Cancer Res (2023) 83 (7_Supplement): 6014.

https://doi.org/10.1158/1538-7445.AM2023-6014

Published: 04 April 2023

View article titled, Abstract 6014: Cancer risk diagnosis by epimutation burden: a multicenter prospective study

Journal Articles

Abstract 6005: Promoter methylation occurs at high frequencies regardless of mutation status of tumor-associated genes in oral malignancies

Masanobu Abe, Kazuto Hoshi, Toshikazu Ushijima

Cancer Res (2023) 83 (7_Supplement): 6005.

https://doi.org/10.1158/1538-7445.AM2023-6005

Published: 04 April 2023

View article titled, Abstract 6005: Promoter methylation occurs at high frequencies regardless of mutation status of tumor-associated genes in oral malignancies

Journal Articles

Abstract 1079: Distinct DNA methylation targets by aging and chronic inflammation

Satoshi Yamashita, Sohachi Nanjo, Emil Rehnberg, Naoko Iida, Hideyuki Takeshima, Takayuki Ando, Takao Maekita, Toshiro Sugiyama, Toshikazu Ushijima

Cancer Res (2020) 80 (16_Supplement): 1079.

https://doi.org/10.1158/1538-7445.AM2020-1079

Published: 15 August 2020

View article titled, Abstract 1079: Distinct DNA methylation targets by aging and chronic inflammation

Journal Articles

Abstract 3056: Development of an integrated CRISPR interference system targeting ΔNp63 to treat lung and esophageal squamous cell carcinoma

Masakazu Yoshida, Etsuko Yokota, Tetsushi Sakuma, Nagio Takigawa, Toshikazu Ushijima, Takashi Yamamoto, Yoshio Naomoto, Takuya Fukazawa, Tomoki Yamatsuji

Cancer Res (2019) 79 (13_Supplement): 3056.

https://doi.org/10.1158/1538-7445.AM2019-3056

Published: 01 July 2019

View article titled, Abstract 3056: Development of an integrated CRISPR interference system targeting ΔNp63 to treat lung and esophageal squamous cell carcinoma

Journal Articles

Abstract 819: DNA methylation genome-wide analysis in remnant gastric cancer

Tomoaki Ito, Kiichi Sugimoto, Hajime Orita, Masahiro Maeda, Hiroshi Moro, Toshikazu Ushijima, Hitoshi Katai, Ryo Wada, Kazuhiro Sakamoto, Koichi Sato, Malcolm V. Brock

Cancer Res (2019) 79 (13_Supplement): 819.

https://doi.org/10.1158/1538-7445.AM2019-819

Published: 01 July 2019

View article titled, Abstract 819: DNA methylation genome-wide analysis in remnant gastric cancer

Journal Articles

Abstract 838: Epigenetic reprogramming of different cancer-related pathways at the single cell level after low-dose DNA demethylation therapy

Hideyuki Takeshima, Yukie Yoda, Naoko Watanabe, Mika Wakabayashi, Toshikazu Ushijima

Cancer Res (2019) 79 (13_Supplement): 838.

https://doi.org/10.1158/1538-7445.AM2019-838

Published: 01 July 2019

View article titled, Abstract 838: Epigenetic reprogramming of different cancer-related pathways at the single cell level after low-dose DNA demethylation therapy

Journal Articles

Abstract 843: Epigenomic disruption of adipogenic regulators in dedifferentiated liposarcoma

Hironori Takamatsu, Naoko Hattori, Naofumi Asano, Naoko Iida, Akihiko Yoshida, Eisuke Kobayashi, Robert Nakayama, Morio Matsumoto, Masaya Nakamura, Akira Kawai, Toshikazu Ushijima

Cancer Res (2019) 79 (13_Supplement): 843.

https://doi.org/10.1158/1538-7445.AM2019-843

Published: 01 July 2019

View article titled, Abstract 843: Epigenomic disruption of adipogenic regulators in dedifferentiated liposarcoma

Journal Articles

Abstract 5340: The methylation burden is determined by the duration of exposure to carcinogenic factors

Harumi Yamada, Hideyuki Takeshima, Tohru Niwa, Takeshi Toyoda, Satoshi Yamashita, Toshikazu Ushijima

Cancer Res (2018) 78 (13_Supplement): 5340.

https://doi.org/10.1158/1538-7445.AM2018-5340

Published: 01 July 2018

View article titled, Abstract 5340: The methylation burden is determined by the duration of exposure to carcinogenic factors

Journal Articles

Abstract 5331: Repression of TET genes and enhancement of DNA methyltransferase activity are critical for induction of aberrant DNA methylation

Hideyuki Takeshima, Tohru Niwa, Harumi Yamada, Satoshi Yamashita, Mika Wakabayashi, Toshikazu Ushijima

Cancer Res (2018) 78 (13_Supplement): 5331.

https://doi.org/10.1158/1538-7445.AM2018-5331

Published: 01 July 2018

View article titled, Abstract 5331: Repression of TET genes and enhancement of DNA methyltransferase activity are critical for induction of aberrant DNA methylation

Journal Articles

PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma

Shoma Tsubota, Satoshi Kishida, Teppei Shimamura, Miki Ohira, Satoshi Yamashita, Dongliang Cao, Shinichi Kiyonari, Toshikazu Ushijima, Kenji Kadomatsu

Cancer Res (2017) 77 (19): 5259–5271.

https://doi.org/10.1158/0008-5472.CAN-16-3144

Published: 01 October 2017

View article titled, PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma

Includes: Supplementary data

Journal Articles

Abstract 4260: Increased mutation burden in normal-appearing lung tissues with high cancer risk

Emi Kubo, Hideyuki Takeshima, Noriko Motoi, Toshikazu Ushijima

Cancer Res (2017) 77 (13_Supplement): 4260.

https://doi.org/10.1158/1538-7445.AM2017-4260

Published: 01 July 2017

View article titled, Abstract 4260: Increased mutation burden in normal-appearing lung tissues with high cancer risk

Journal Articles

Abstract 921: Cdyl2 is a chromodomain protein involved in the maintenance of pluripotency of stem cells

Naoko Hattori, Kana Kimura, Jumpei Taguchi, Toshio Imai, Yasuhiro Yamada, Toshikazu Ushijima

Cancer Res (2017) 77 (13_Supplement): 921.

https://doi.org/10.1158/1538-7445.AM2017-921

Published: 01 July 2017

View article titled, Abstract 921: Cdyl2 is a chromodomain protein involved in the maintenance of pluripotency of stem cells

Journal Articles

Abstract LB-092: High impact of methylation accumulation on cancer risk: 5-year follow-up of a multicenter prospective cohort study

Masahiro Maeda, Takeshi Nakajima, Ichiro Oda, Taichi Shimazu, Nobutake Yamamichi, Takao Maekita, Kiyoshi Asada, Chizu Yokoi, Takayuki Ando, Takeichi Yoshida, Sohachi Nanjo, Mitsuhiro Fujishiro, Takuji Gotoda, Masao Ichinose, Toshikazu Ushijima

Cancer Res (2017) 77 (13_Supplement): LB-092.

https://doi.org/10.1158/1538-7445.AM2017-LB-092

Published: 01 July 2017

View article titled, Abstract LB-092: High impact of methylation accumulation on cancer risk: 5-year follow-up of a multicenter prospective cohort study

Journal Articles

The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer

Toshikazu Ushijima, Takayuki Yoshino

Cancer Res (2016) 76 (22): 6443–6444.

https://doi.org/10.1158/0008-5472.CAN-16-2867

Published: 14 November 2016

View article titled, The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract LB310: Methylation synthetic lethality: SMARCA1 methylation and inhibition of pyrimidine synthesis

Abstract 695: Relative importance between DNA methylation and mutation in nonmalignant tissue for cancer risk

Abstract 7016: Plastic epigenome in youth: Insights from open chromatin in stem cells

Abstract 4410: The CpG island methylator phenotype is closely associated with prognosis in patients with oral squamous cell carcinomas

Abstract 6024: Precancerous nature of intestinal metaplasia with accelerated DNA methylation along with altered epigenomic landscape

Abstract 6015: Methylation synthetic lethality: CHFR methylation and KRAS inhibition in gastric cancers

Abstract 6014: Cancer risk diagnosis by epimutation burden: a multicenter prospective study

Abstract 6005: Promoter methylation occurs at high frequencies regardless of mutation status of tumor-associated genes in oral malignancies

Abstract 1079: Distinct DNA methylation targets by aging and chronic inflammation

Abstract 3056: Development of an integrated CRISPR interference system targeting ΔNp63 to treat lung and esophageal squamous cell carcinoma

Abstract 819: DNA methylation genome-wide analysis in remnant gastric cancer

Abstract 838: Epigenetic reprogramming of different cancer-related pathways at the single cell level after low-dose DNA demethylation therapy

Abstract 843: Epigenomic disruption of adipogenic regulators in dedifferentiated liposarcoma

Abstract 5340: The methylation burden is determined by the duration of exposure to carcinogenic factors

Abstract 5331: Repression of TET genes and enhancement of DNA methyltransferase activity are critical for induction of aberrant DNA methylation

PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma

Abstract 4260: Increased mutation burden in normal-appearing lung tissues with high cancer risk

Abstract 921: Cdyl2 is a chromodomain protein involved in the maintenance of pluripotency of stem cells

Abstract LB-092: High impact of methylation accumulation on cancer risk: 5-year follow-up of a multicenter prospective cohort study

The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

AACR Journals
on Social Media